Biopharma Insights - page 18

Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements

In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and Endogena Therapeutics AG have forged a strong partnership to drive …

Continue ›››

Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies

Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American Association for Cancer Research's Annual Meeting (AACR 2023). The company …

Continue ›››

FDA Collaborates with Cerner Enviza and John Snow Labs to Harness AI and EHR Data Analytics for Pharmacovigilance

Cerner Enviza, an Oracle company, and John Snow Labs have been selected by the FDA's Sentinel Innovation Center to support the Sentinel Initiative, focusing on AI drug discovery and real-world …

Continue ›››

PsychoGenics Introduces eCube, an AI-Driven Platform for Drug Discovery in Neuropsychiatric Disorders

PsychoGenics, a prominent player in AI-enabled phenotypic drug discovery and preclinical CRO services, has recently unveiled eCube, an innovative pharmaco-electroencephalography (pharmacoEEG) platform designed to enhance phenotypic drug discovery. By employing …

Continue ›››

Some Drugs That Improve Price Competition Fall Through The Cracks Of FDA User Fees

Americans are increasingly concerned about rising drug prices. FDA user fees affect drug pricing competition, which is often overlooked. FDA user fees fund regulatory activities and encourage timely reviews and …

Continue ›››

ConcertAI Unveils Next-Generation Clinical Trial Optimization Platform, CTO 2.0

ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced the launch of its Clinical Trial Optimization (CTO 2.0) platform. The …

Continue ›››

Introducing “Lab-on-a-Molecule” Drug Discovery Approach via DNA Nanoswitches

The challenge faced by current compound screening approaches often lies in their limitations, either in throughput or their capacity to screen for the complex ways disease-relevant molecules can be functionally …

Continue ›››

Introducing PathExplore, a Game-Changing AI Tool for In-Depth Tumor Microenvironment Exploration

As we continue to make progress in oncology therapeutics, researchers are constantly seeking ways to improve patient outcomes by understanding the complexities of the tumor microenvironment (TME). In response to …

Continue ›››

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

Researchers from MIT and the University of Massachusetts Medical School have developed a new type of lipid nanoparticle designed to deliver messenger RNA (mRNA) to the lungs. This innovative approach …

Continue ›››

AI-Powered Peptide Discovery from Plant Sources Leads to a Breakthrough In Muscle Recovery

Nuritas, an innovator in AI-based peptide discovery from natural sources, has announced the results of a second clinical trial on its patented ingredient, PeptiStrong™. The ingredient, which is sourced from …

Continue ›››

AbSci and Other AI-Powered Biotechs Lead the Way in Antibody Discovery

The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The success of these therapeutics has driven the pharma industry to …

Continue ›››

QSimulate Launches Quantum Fingerprinting Product to Improve AI Drug Discovery

The field of drug discovery has witnessed a massive transformation in recent years, thanks to the integration of artificial intelligence (AI) methods that have accelerated the pace of research. With …

Continue ›››